Analytical Data
-
基因名
ACP2
- Application
-
别名
Lysosomal Acid Phosphatase
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P11117
-
表达区间
Tyr40~Ala250
-
分子量
29kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ACP2 (Acidic Characteristics Protein 2) is a member of the serine protease family that has garnered attention in the field of biomedical research due to its potential roles in various physiological and pathological processes. Initially identified in mouse models, ACP2 has been linked to critical functions in immune response, cell signaling, and tissue remodeling. Dysregulation of ACP2 has been implicated in several diseases, including cancer, neurodegenerative disorders, and inflammatory conditions, underscoring the importance of understanding its molecular mechanisms. The recombinant expression of ACP2 provides a valuable tool for studying its enzymatic activity, substrate specificity, and interaction with other proteins. Additionally, researchers are exploring the therapeutic potential of ACP2 through the development of specific inhibitors or modulators that could mitigate its pathological effects. The advancements in recombinant DNA technology and protein purification techniques have facilitated the production of high-quality ACP2 protein, paving the way for detailed structural studies and functional assays. These investigations aim not only to elucidate the biology of ACP2 but also to explore its potential as a biomarker for disease progression and treatment response, thus highlighting its significance in translational medicine.
